Bemcentinib-d8

SI-6507

Bemcentinib-d₈, >98% (HPLC)

Synonyms : BGB-324-d₈; R-428-d₈

IUPAC Name : (S)-1-(6,7-Dihydro-5H-benzo[6,7]cyclohepta[1,2-c]pyridazin-3-yl)-N3-(7-(pyrrolidin-1-yl-d₈)-6,7,8,9-tetrahydro-5H-benzo[7]annulen-2-yl)-1H-1,2,4-triazole-3,5-diamine

Price And Availability
Pack Size	Price in USD	Add To Shopping Cart	Availability	Shipping Status
5MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
10MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
25MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026

Applications : Bemcentinib‑d8 is a deuterium-labelled version of Bemcentinib. This can be used as an analytical labelled reference standard. Bemcentinib is a selective AXL inhibitor (IC₅₀ = 14 nM) that blocks metastasis and improves survival in breast cancer models.

References :
Sensi M. et al.: J. Invest. Dermatol., 131(12), 2448-57, 2011; Holland S. J. et al.: Cancer Res., 70(4), 1544-54, 2010.

Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.